AA	arachidonic acid
ACM	arrhythmogenic cardiomyopathy
ACS	acute coronary syndrome
ADP	adenosine diphosphate
Ago2	Argonaute 2
AMI	acute myocardial infarction
ASA	acetylsalicylic acid (aspirin)
CAD	coronary artery disease
CRP-XL	crosslinked collagen-related peptide
CTAD	citrate-theophylline-adenosine-dipyridamole
CVD	cardiovascular disease
DAPT	dual antiplatelet therapy
EC	endothelial cell
EDTA	ethylenediaminetetraacetic acid
EV	extracellular vesicle
HSC	hematopoietic stem cell
HTPR	high on treatment platelet reactivity
HUVEC	human umbilical vein endothelial cell
IVD	in vitro diagnostic
LD	loading dose
LNA	locked nucleic acid
LTA	light transmission aggregometry
MACE	major adverse cardiac event
MD	maintenance dose
MEA	multiple electrode aggregometry
MI	myocardial infarction
miRNA	microRNA
mRNA	messenger RNA
MRP4	multidrug resistance protein 4
ncRNA	noncoding RNA
PAR2-AP	protease-activated receptor-2 activating peptide
PAR4-AP	protease-activated receptor-4 activating peptide
PBMC	peripheral blood mononuclear cells
PCI	percutaneous coronary intervention
PCR	polymerase chain reaction
PE	pulmonary embolism
PFT	platelet function test
PMV	platelet microvesicle
POC	point-of-care
PPP	platelet-poor plasma
pre-miRNA	precursor miRNA
PRP	platelet-rich plasma
PV	polycythemia vera
RT-qPCR	real-time polymerase chain reaction
SMC	smooth muscle cell
T2DM	type 2 diabetes mellitus
TEG	thromboelastography
TRAP	thrombin receptor activating peptide
UTR	untranslated region
VASP	vasodilator-stimulated phosphoprotein phosphorylation